These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

985 related articles for article (PubMed ID: 32948836)

  • 41. cGAS-STING signaling pathway in intestinal homeostasis and diseases.
    Yang Y; Wang L; Peugnet-González I; Parada-Venegas D; Dijkstra G; Faber KN
    Front Immunol; 2023; 14():1239142. PubMed ID: 37781354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways.
    Zevini A; Olagnier D; Hiscott J
    Trends Immunol; 2017 Mar; 38(3):194-205. PubMed ID: 28073693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders.
    Huang Y; Liu B; Sinha SC; Amin S; Gan L
    Mol Neurodegener; 2023 Nov; 18(1):79. PubMed ID: 37941028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of cGAS-STING signalling in cancer: Approach for combination therapy.
    Vasiyani H; Wadhwa B; Singh R
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188896. PubMed ID: 37088059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection.
    Hu Y; Chen B; Yang F; Su Y; Yang D; Yao Y; Wang S; Wu Y; Tao L; Xu T
    Autoimmun Rev; 2022 Sep; 21(9):103155. PubMed ID: 35902046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitotic inactivation of the cGAS‒MITA/STING pathways.
    Zhong L; Shu HB
    J Mol Cell Biol; 2021 Dec; 13(10):721-727. PubMed ID: 34609492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cGAS-STING-autophagy pathway: Novel perspectives in neurotoxicity induced by manganese exposure.
    Zhang X; Liu J; Wang H
    Environ Pollut; 2022 Dec; 315():120412. PubMed ID: 36240967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors.
    Tian X; Xu F; Zhu Q; Feng Z; Dai W; Zhou Y; You QD; Xu X
    Eur J Med Chem; 2022 Dec; 244():114791. PubMed ID: 36206657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. cGAS- Stimulator of Interferon Genes Signaling in Central Nervous System Disorders.
    Li F; Wang N; Zheng Y; Luo Y; Zhang Y
    Aging Dis; 2021 Oct; 12(7):1658-1674. PubMed ID: 34631213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of micronucleus-activated cGAS-STING signaling in antitumor immunity.
    Shen Q; Xu P; Mei C
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):25-34. PubMed ID: 38273467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of the cGAS-STING pathway in systemic and organ-specific diseases.
    Skopelja-Gardner S; An J; Elkon KB
    Nat Rev Nephrol; 2022 Sep; 18(9):558-572. PubMed ID: 35732833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer.
    Kwon J; Bakhoum SF
    Cancer Discov; 2020 Jan; 10(1):26-39. PubMed ID: 31852718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The GRA15 protein from
    Wang P; Li S; Zhao Y; Zhang B; Li Y; Liu S; Du H; Cao L; Ou M; Ye X; Li P; Gao X; Wang P; Jing C; Shao F; Yang G; You F
    J Biol Chem; 2019 Nov; 294(45):16494-16508. PubMed ID: 31416833
    [No Abstract]   [Full Text] [Related]  

  • 54. Research progress of cGAS-STING signaling pathway in intestinal diseases.
    Wang J; Yao N; Chen Y; Li X; Jiang Z
    Int Immunopharmacol; 2024 Jun; 135():112271. PubMed ID: 38762923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mitochondrial DNA and cGAS-STING Innate Immune Signaling Pathway: Latest Research Progress].
    Li YX; Cui SF; Meng W; Hu HY; Wang C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):387-395. PubMed ID: 34018355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis.
    Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
    J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The cGAS-STING pathway: Post-translational modifications and functional implications in diseases.
    Liu J; Rui K; Peng N; Luo H; Zhu B; Zuo X; Lu L; Chen J; Tian J
    Cytokine Growth Factor Rev; 2022 Dec; 68():69-80. PubMed ID: 36151014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment.
    Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ
    Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Control of innate immunity by the cGAS-STING pathway.
    Mosallanejad K; Kagan JC
    Immunol Cell Biol; 2022 Jul; 100(6):409-423. PubMed ID: 35485309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Herpes Simplex Virus 1 Abrogates the cGAS/STING-Mediated Cytosolic DNA-Sensing Pathway via Its Virion Host Shutoff Protein, UL41.
    Su C; Zheng C
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.